NCT01159574 · OUTCOME

Time to Disease Progression (Progression Free Survival)

Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma · Source last updated 2019-06-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: days
Interval / dispersion: Full Range
Time frame: From start of treatment, to date of disease progression

Analysis population: 18 patients were removed from study for reasons other then disease progression; 2 patients are still receiving treatment.

Groups in this outcome

All Patients

ClaPd therapy: Dexamethasone (40mg ) will be given on days 1, 8, 15, 22 of a 28-day cycle. Clarithromycin (Biaxin®) will be given orally at a dose of 500 mg twice a day on days 1-28 of a 28 day cycle. Pomalidomide will be given 4mg daily for days 1-21 of each 28 day cycle. Dosing will be in the morning at approximately the same time each day. dexamethasone: 40mg will be given on days 1, 8, 15, 22 of a 28-day cycle clarithromycin: orally at a dose of 500 mg twice a day on days 1-28 of a 28 day cycle Pomalidomide: orally 4mg daily for days 1-21 of each 28 day cycle

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
All Patients	100

Reported measurements

Source class 1

Values in days · Interval/dispersion: Full Range
Group	Value	Spread	Lower	Upper	Comment
All Patients	272	Not reported	21	1430	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
21
upper Limit
1430
value
272

denoms

counts
group Id
OG000
value
100
units
Participants

dispersion Type

Full Range

groups

description
ClaPd therapy: Dexamethasone (40mg ) will be given on days 1, 8, 15, 22 of a 28-day cycle. Clarithromycin (Biaxin®) will be given orally at a dose of 500 mg twice a day on days 1-28 of a 28 day cycle. Pomalidomide will be given 4mg daily for days 1-21 of each 28 day cycle. Dosing will be in the morning at approximately the same time each day. dexamethasone: 40mg will be given on days 1, 8, 15, 22 of a 28-day cycle clarithromycin: orally at a dose of 500 mg twice a day on days 1-28 of a 28 day cycle Pomalidomide: orally 4mg daily for days 1-21 of each 28 day cycle
id
OG000
title
All Patients

param Type

MEAN

population Description

18 patients were removed from study for reasons other then disease progression; 2 patients are still receiving treatment.

reporting Status

POSTED

time Frame

From start of treatment, to date of disease progression

title

Time to Disease Progression (Progression Free Survival)

type

SECONDARY

unit Of Measure

days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice